Press Release
NPS Pharmaceuticals to Webcast Presentation at Goldman Sachs 28th Annual Global Healthcare Conference
PARSIPPANY, N.J., June 11 /PRNewswire-FirstCall/ -- NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) announced today that Dr. Anthony Coles, president and CEO, will present a company update at the Goldman Sachs 28th Annual Global Healthcare Conference in Dana Point, California at 8:00 a.m. PDT on Thursday, June 14, 2007. The live event webcast may be accessed on the NPS site, http://www.npsp.com. A replay will be available approximately three hours after the presentation has concluded and may be accessed at the same link.
About NPS Pharmaceuticals
NPS discovers and develops small molecules and recombinant proteins as drugs, primarily for the treatment of metabolic, bone and mineral, and central nervous system disorders. The company has drug candidates in various stages of clinical development backed by a strong discovery research effort. Additional information is available on the company's website, http://www.npsp.com.
SOURCE NPS Pharmaceuticals, Inc.
06/11/2007
CONTACT: Brandi Simpson, Sr. Director, Investor Relations of NPS
Pharmaceuticals, Inc., +1-801-583-4939
Company News On-Call: http://www.prnewswire.com/comp/613587.html
Web site: http://www.npsp.com
(NPSP)
The reports filed by NPS with the Securities and Exchange Commission and the news releases issued by NPS and posted on this website are current only as of the dates on which they were filed or issued by NPS. Therefore, the contents of these reports and releases can become outdated. We make no commitment, and disclaim any duty, to update these reports and releases. We do not warrant the accuracy or completeness of these materials or the reliability of any advice, opinion, statement or other information displayed or distributed through the website. Readers acknowledge that any reliance on these reports, releases, advice, opinions, statements, or information are at the reader’s sole risk.